Our results show an upregulation of NLRP3 in the well-established in vitro model for chronic muscle inflammation, as used for IBM [11] upon stimulation with IL-1β and IFN-γ for 24 h, 48 h, and 72 h, creating a proinflammatory milieu. The gene discussed is NLRP3; the disease is inflammatory response.